AB
PDLI

Amalgamated Bank’s PDL BioPharma, Inc. PDLI Stock Holding History

Amalgamated Bank’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-17,519
Closed -$49K – 1751
2020
Q1 		$49K Sell
17,519
-365
-2% -$1.18K ﹤0.01% 1569
2019
Q4 		$58K Buy
17,884
+665
+4% +$1.93K ﹤0.01% 1781
2019
Q3 		$37K Sell
17,219
-142
-0.8% -$380 ﹤0.01% 1737
2019
Q2 		$55K Sell
17,361
-3,373
-16% -$10.9K ﹤0.01% 1741
2019
Q1 		$77K Buy
20,734
+748
+4% +$2.52K ﹤0.01% 1618
2018
Q4 		$58K Hold
19,986
– – ﹤0.01% 1554
2018
Q3 		$53K Sell
19,986
-528
-3% -$1.3K ﹤0.01% 1419
2018
Q2 		$48K Buy
20,514
+546
+3% +$1.52K ﹤0.01% 1707
2018
Q1 		$59K Sell
19,968
-593
-3% -$1.62K ﹤0.01% 1560
2017
Q4 		$56K Buy
20,561
+794
+4% +$2.44K ﹤0.01% 1605
2017
Q3 		$67K Sell
19,767
-432
-2% -$1.2K ﹤0.01% 1533
2017
Q2 		$50K Sell
20,199
-553
-3% -$1.27K ﹤0.01% 1546
2017
Q1 		$47K Buy
20,752
+15
+0.1% +$33 ﹤0.01% 1473
2016
Q4 		$44K Buy
20,737
+2,647
+15% +$7.39K ﹤0.01% 1486
2016
Q3 		$61K Buy
18,090
+59
+0.3% +$187 ﹤0.01% 1356
2016
Q2 		$53K Buy
18,031
+376
+2% +$1.25K ﹤0.01% 1354
2016
Q1 		$59K Buy
17,655
+1,707
+11% +$5.32K 0.01% 1252
2015
Q4 		$56K Sell
15,948
-1,202
-7% -$5.03K 0.01% 1170
2015
Q3 		$86K Buy
17,150
+217
+1% +$1.24K 0.01% 1244
2015
Q2 		$109K Buy
16,933
+624
+4% +$4.18K 0.01% 1298
2015
Q1 		$115K Buy
16,309
+626
+4% +$4.53K 0.01% 904
2014
Q4 		$121K Buy
15,683
+22
+0.1% +$174 0.02% 827
2014
Q3 		$117K Sell
15,661
-8
-0.1% -$74 0.02% 813
2014
Q2 		$152K Sell
15,669
-809
-5% -$7.21K 0.02% 835
2014
Q1 		$137K Buy
16,478
+1,955
+13% +$16.8K 0.02% 790
2013
Q4 		$123K Buy
+14,523
New +$122K 0.02% 796

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

Amalgamated Bank's PDLI Position: Q2 2020 in Review

Amalgamated Bank sold out of PDL BioPharma, Inc. (PDLI) in Q2 2020, closing a stake of 17,519 shares — an estimated $49K sold.

Amalgamated Bank first reported a position in PDLI in Q4 2013 and held it in 26 quarters. The position peaked at $152K in Q2 2014. 136 funds tracked by Wall St. Rank hold PDLI as of Q2 2020.

  • Amalgamated Bank reported no remaining PDL BioPharma, Inc. position as of Q2 2020 after selling out during the quarter.
  • Amalgamated Bank sold 17,519 PDL BioPharma, Inc. shares in Q2 2020, an estimated $49K.
  • Amalgamated Bank first reported a position in PDL BioPharma, Inc. in Q4 2013 and held it in 26 quarters.
  • Amalgamated Bank's PDL BioPharma, Inc. position peaked at $152K in Q2 2014.
  • 136 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2020.

Based on Amalgamated Bank's 13F filing for Q2 2020, filed 10 Aug 2020.